MCM10, a potential diagnostic, immunological, and prognostic biomarker in pan-cancer.

Sci Rep · 2023 · PMC10582070 · PMID 37848534

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

MCM10 may be a good target for tumor immunotherapy and may be significant in tumor immunotherapy, according to the significant association between MCM10 and immunological checkpoints.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.